Pharmacokinetics of lenalidomide administered as single ascending doses in Japanese or Caucasian volunteers

Trial Profile

Pharmacokinetics of lenalidomide administered as single ascending doses in Japanese or Caucasian volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2013

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Acute myeloid leukaemia; Adult T-cell leukaemia-lymphoma; Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Follicular lymphoma; Glioblastoma; Mantle-cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Myelofibrosis; Non-Hodgkin's lymphoma; Peripheral T-cell lymphoma; Prostate cancer
  • Focus Pharmacokinetics
  • Sponsors Celgene Corporation
  • Most Recent Events

    • 31 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top